Abstract
After participating in this activity on chronic obstructive pulmonary disease (COPD), family physicians will be better able to: Identify symptomatic patients at increased risk of COPD to prompt early diagnostic evaluation. Individualize evidence-based therapy with the goal of reducing COPD exacerbations and improving patient outcomes. Identify the role of fixed triple-combination inhalers as part of individualized therapy.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-2 Receptor Agonists / therapeutic use
-
Aftercare / methods
-
Bronchodilator Agents / therapeutic use
-
Disease Progression
-
Humans
-
Mass Screening / methods
-
Pulmonary Disease, Chronic Obstructive / complications*
-
Pulmonary Disease, Chronic Obstructive / drug therapy
-
Pulmonary Disease, Chronic Obstructive / prevention & control*
Substances
-
Adrenergic beta-2 Receptor Agonists
-
Bronchodilator Agents